PeptideDB

Clodronate disodium tetrahydrate 88416-50-6

Clodronate disodium tetrahydrate 88416-50-6

CAS No.: 88416-50-6

Clodronate disodium tetrahydrate (Disodium clodronate tetrahydrate) is a first-generation bisphosphonate that has anti-o
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Clodronate disodium tetrahydrate (Disodium clodronate tetrahydrate) is a first-generation bisphosphonate that has anti-osteoporotic and anti~inflammatory effects and may be utilized in pain relief research. Clodronate disodium tetrahydrate is a selective, highly efficient, reversible, Cl-competitive vesicular nucleotide transporter (VNUT) blocker with IC50 of 15.6 nM. Clodronate disodium tetrahydrate can inhibit the release of vesicular ATP from neurons and relieve chronic neuropathic pain and inflammatory pain.

Physicochemical Properties


Molecular Formula CH2CL2NA2O6P2
Molecular Weight 288.8560
Exact Mass 359.892
CAS # 88416-50-6
Related CAS # Clodronic acid disodium salt;22560-50-5;Clodronic acid;10596-23-3
PubChem CID 23724874
Appearance White to off-white solid powder
LogP 1.049
Hydrogen Bond Donor Count 6
Hydrogen Bond Acceptor Count 10
Rotatable Bond Count 2
Heavy Atom Count 17
Complexity 206
Defined Atom Stereocenter Count 0
InChi Key XWHPUCFOTRBMGS-UHFFFAOYSA-L
InChi Code

InChI=1S/CH4Cl2O6P2.2Na.4H2O/c2-1(3,10(4,5)6)11(7,8)9;;;;;;/h(H2,4,5,6)(H2,7,8,9);;;4*1H2/q;2*+1;;;;/p-2
Chemical Name

disodium;[dichloro-[hydroxy(oxido)phosphoryl]methyl]-hydroxyphosphinate;tetrahydrate
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro Clodronate disodium tetrahydrate is a first-generation bisphosphonate that acts by blocking VNUT, a crucial molecule that starts purinergic chemical events, to greatly reduce neuropathic and neuropathic pain unrelated to disruptive disorders [1]. connection as a medication that resists bone absorption [2].
ln Vivo By blocking VNUT, clodronate tetrahydrate (10 mg/kg; IV) reduces accommodative discomfort [1]. Disodium clodronate tetrahydrate inhibits VNUT, which reduces accommodative pain [1].
Animal Protocol Animal/Disease Models: C57BL/6 mice (22-30 g) [1]
Doses: 10 mg/kg
Route of Administration: intravenous (iv) (iv)injection
Experimental Results: Reduce inflammatory pain caused by carrageenan or complete Freund's adjuvant (CFA) .
References

[1]. Identification of a vesicular ATP release inhibitor for the treatment of neuropathic and inflammatory pain. Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):E6297-E6305.

[2]. Clodronate: A Vesicular ATP Release Blocker. Trends Pharmacol Sci. 2018 Jan;39(1):13-23.

Additional Infomation Disodium clodronate tetrahydrate is the tetrahydrate of the disodium salt of clodronic acid. It inhibits bone resorption and soft tissue calcification, and is used as an adjunct in the treatment of severe hypercalcaemia associated with malignancy, and in the management of osteolytic lesions and bone pain associated with skeletal metastases. It has a role as a bone density conservation agent. It is a hydrate and a one-carbon compound. It contains a clodronic acid disodium salt.
Clodronate Disodium is the disodium salt of a nitrogen-free bisphosphonate analog of naturally occurring pyrophosphate. Clodronate binds to calcium and inhibits osteoclastic bone resorption and hydroxyapatite crystal formation and dissolution, resulting in a reduction of bone turnover. This agent may control malignancy-associated hypercalcemia, inhibit osteolytic bone metastasis and decrease pain.
A diphosphonate which affects calcium metabolism. It inhibits bone resorption and soft tissue calcification.

Solubility Data


Solubility (In Vitro) H2O : ~125 mg/mL (~346.34 mM)
Solubility (In Vivo) Solubility in Formulation 1: 25 mg/mL (69.27 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with heating and sonication.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.4619 mL 17.3094 mL 34.6188 mL
5 mM 0.6924 mL 3.4619 mL 6.9238 mL
10 mM 0.3462 mL 1.7309 mL 3.4619 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.